123 related articles for article (PubMed ID: 33075016)
1. JMJD1C knockdown affects myeloid cell lines proliferation, viability, and gemcitabine/carboplatin-sensitivity.
Schimek V; Björn N; Pellé L; Svedberg A; Gréen H
Pharmacogenet Genomics; 2021 Apr; 31(3):60-67. PubMed ID: 33075016
[TBL] [Abstract][Full Text] [Related]
2. shRNA screening identifies JMJD1C as being required for leukemia maintenance.
Sroczynska P; Cruickshank VA; Bukowski JP; Miyagi S; Bagger FO; Walfridsson J; Schuster MB; Porse B; Helin K
Blood; 2014 Mar; 123(12):1870-82. PubMed ID: 24501218
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II.
Zhang S; Lu Y; Jiang C
J Recept Signal Transduct Res; 2020 Aug; 40(4):339-347. PubMed ID: 32122211
[TBL] [Abstract][Full Text] [Related]
4. The histone demethylase JMJD1C regulates CPS1 expression and promotes the proliferation of paroxysmal nocturnal haemoglobinuria clones through cell metabolic reprogramming.
Chen Y; Liu H; Wang C; Chen W; Li L; Wu J; Wang G; Ling GS; Fu R
Br J Haematol; 2024 Jun; 204(6):2468-2479. PubMed ID: 38650379
[TBL] [Abstract][Full Text] [Related]
5. JMJD1C Regulates Megakaryopoiesis in In Vitro Models through the Actin Network.
Wang J; Liu X; Wang H; Qin L; Feng A; Qi D; Wang H; Zhao Y; Kong L; Wang H; Wang L; Hu Z; Xu X
Cells; 2022 Nov; 11(22):. PubMed ID: 36429088
[TBL] [Abstract][Full Text] [Related]
6. Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia.
Izaguirre-Carbonell J; Christiansen L; Burns R; Schmitz J; Li C; Mokry RL; Bluemn T; Zheng Y; Shen J; Carlson KS; Rao S; Wang D; Zhu N
Blood Adv; 2019 May; 3(9):1499-1511. PubMed ID: 31076406
[TBL] [Abstract][Full Text] [Related]
7. AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase.
Yoshihama Y; LaBella KA; Kim E; Bertolet L; Colic M; Li J; Shang X; Wu CJ; Spring DJ; Wang YA; Hart T; DePinho RA
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34475205
[TBL] [Abstract][Full Text] [Related]
8. Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells.
Xu X; Wang L; Hu L; Dirks WG; Zhao Y; Wei Z; Chen D; Li Z; Wang Z; Han Y; Wei L; Drexler HG; Hu Z
Int J Cancer; 2020 Jan; 146(2):400-412. PubMed ID: 31271662
[TBL] [Abstract][Full Text] [Related]
9. JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors.
Chen M; Zhu N; Liu X; Laurent B; Tang Z; Eng R; Shi Y; Armstrong SA; Roeder RG
Genes Dev; 2015 Oct; 29(20):2123-39. PubMed ID: 26494788
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell RNA Sequencing of Hematopoietic Stem and Progenitor Cells Treated with Gemcitabine and Carboplatin.
Björn N; Jakobsen I; Lotfi K; Gréen H
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32422951
[TBL] [Abstract][Full Text] [Related]
11. Modulators of histone demethylase JMJD1C selectively target leukemic stem cells.
Yang Y; Zhang X; Zhang X; Wang Y; Wang X; Hu L; Zhao Y; Wang H; Wang Z; Wang H; Wang L; Dirks WG; Drexler HG; Xu X; Hu Z
FEBS Open Bio; 2021 Jan; 11(1):265-277. PubMed ID: 33289299
[TBL] [Abstract][Full Text] [Related]
12. JMJD1C-regulated lipid synthesis contributes to the maintenance of
Qi D; Wang J; Zhao Y; Yang Y; Wang Y; Wang H; Wang L; Wang Z; Xu X; Hu Z
Leuk Lymphoma; 2022 Sep; 63(9):2149-2160. PubMed ID: 35468015
[No Abstract] [Full Text] [Related]
13. Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures.
Slavotinek A; van Hagen JM; Kalsner L; Pai S; Davis-Keppen L; Ohden L; Weber YG; Macke EL; Klee EW; Morava E; Gunderson L; Person R; Liu S; Weiss M
Eur J Med Genet; 2020 Apr; 63(4):103850. PubMed ID: 31954878
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase JMJD1C promotes the polarization of M1 macrophages to prevent glioma by upregulating miR-302a.
Zhong C; Tao B; Yang F; Xia K; Yang X; Chen L; Peng T; Xia X; Li X; Peng L
Clin Transl Med; 2021 Sep; 11(9):e424. PubMed ID: 34586733
[TBL] [Abstract][Full Text] [Related]
15. JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.
Lynch JR; Salik B; Connerty P; Vick B; Leung H; Pijning A; Jeremias I; Spiekermann K; Trahair T; Liu T; Haber M; Norris MD; Woo AJ; Hogg P; Wang J; Wang JY
Leukemia; 2019 Jun; 33(6):1400-1410. PubMed ID: 30622285
[TBL] [Abstract][Full Text] [Related]
16. Comparative integromics on JMJD1C gene encoding histone demethylase: conserved POU5F1 binding site elucidating mechanism of JMJD1C expression in undifferentiated ES cells and diffuse-type gastric cancer.
Katoh M; Katoh M
Int J Oncol; 2007 Jul; 31(1):219-23. PubMed ID: 17549425
[TBL] [Abstract][Full Text] [Related]
17. Mutations in JMJD1C are involved in Rett syndrome and intellectual disability.
Sáez MA; Fernández-Rodríguez J; Moutinho C; Sanchez-Mut JV; Gomez A; Vidal E; Petazzi P; Szczesna K; Lopez-Serra P; Lucariello M; Lorden P; Delgado-Morales R; de la Caridad OJ; Huertas D; Gelpí JL; Orozco M; López-Doriga A; Milà M; Perez-Jurado LA; Pineda M; Armstrong J; Lázaro C; Esteller M
Genet Med; 2016 Apr; 18(4):378-85. PubMed ID: 26181491
[TBL] [Abstract][Full Text] [Related]
18. Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.
Lee YL; Chen CW; Liu FH; Huang YW; Huang HM
PLoS One; 2013; 8(4):e61939. PubMed ID: 23613979
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of miR-302 by JMJD1C inhibits neural differentiation of human embryonic stem cells.
Wang J; Park JW; Drissi H; Wang X; Xu RH
J Biol Chem; 2014 Jan; 289(4):2384-95. PubMed ID: 24318875
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine/carboplatin in advanced non-small cell lung cancer.
Zatloukal P; Petruzelka L
Lung Cancer; 2002 Nov; 38 Suppl 2():S33-6. PubMed ID: 12431827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
